Drug class
Polymyxin E cyclic lipopeptide antibacterial; outer-membrane disruptor
Mechanism of action
Binds lipopolysaccharide and phospholipids in the outer membrane of Gram-negative bacteria, displacing stabilising divalent cations and disrupting membrane integrity, causing leakage of intracellular contents and bacterial death.
General use cases
- Treatment of serious infections caused by susceptible multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa, Acinetobacter baumannii and selected Enterobacterales, using systemic formulations under specialist supervision
- Topical or otic formulations have separate route-specific indications; systemic use is limited by nephrotoxicity and neurotoxicity
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
